Mammatech Announces Reverse Split, Company Developing Tactile Computer to Improve Clinical Breast Exams - CBE's - (Amended Press Release - The company's release dated November 12, 2004 contained an error and should be disregarded in favor of the following amended version)
11/15/2004 11:51:00 AM
GAINESVILLE, Fla., Nov 15, 2004 (BUSINESS WIRE) -- The Mammatech Corporation (MAMH) announced today that it anticipates a 20 to 1 reverse split in the company's shares of common stock effective 22 November 2004. The Company's Form 8-K stated that it intends to seek financing for new product development. H.S. Pennypacker, Ph.D., President of Mammatech, said "the company is developing computer assisted tactile trainer that will help produce and verify high levels of clinical breast examination (CBE) skill." Dr. Mark K. Goldstein, Mammatech's Chairman, reported that published studies continue to find that most breast cancers are first detected by someone's hands. The Company's MammaCare(R) program is the recognized standard for proficient CBE(1) MammaCare as developed by Mammatech scientists with grant support from the National Cancer Institute.
(1) Barton, M. B., Harris, R., & Fletcher, S. W. (1999). Does this patient have breast cancer? The screening clinical breast examination: Should it be done? How? Journal of the American Medical Association, 282(13), 1270-1280.
The company's transfer agent is
Manhattan Transfer Registrar Company
57 Eastwood Road
Miller Place, NY 11764
SOURCE: The Mammatech Corporation
The Mammatech Corporation, Gainesville
Mark Goldstein, Ph.D., 352-375-0607
web site: mammacare.com
email science@mammacare.com
. |
